MIG Capital LLC Purchases Shares of 149,163 Humana Inc. (NYSE:HUM)

MIG Capital LLC purchased a new position in shares of Humana Inc. (NYSE:HUM - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 149,163 shares of the insurance provider's stock, valued at approximately $37,844,000. Humana makes up approximately 3.9% of MIG Capital LLC's investment portfolio, making the stock its 13th largest position. MIG Capital LLC owned approximately 0.12% of Humana as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. FPC Investment Advisory Inc. purchased a new position in shares of Humana during the 4th quarter worth approximately $27,000. Centricity Wealth Management LLC acquired a new position in Humana during the fourth quarter worth $30,000. LFA Lugano Financial Advisors SA raised its position in Humana by 56.3% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider's stock worth $32,000 after acquiring an additional 45 shares in the last quarter. OFI Invest Asset Management acquired a new stake in Humana in the fourth quarter valued at $33,000. Finally, Atwood & Palmer Inc. boosted its position in shares of Humana by 64.5% during the 4th quarter. Atwood & Palmer Inc. now owns 153 shares of the insurance provider's stock worth $39,000 after purchasing an additional 60 shares in the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Analyst Ratings Changes

A number of brokerages have recently issued reports on HUM. Barclays raised their price objective on shares of Humana from $255.00 to $270.00 and gave the company an "equal weight" rating in a research note on Thursday, February 13th. JPMorgan Chase & Co. reduced their price target on shares of Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a research report on Tuesday, February 18th. Truist Financial upped their price target on Humana from $290.00 to $325.00 and gave the stock a "hold" rating in a report on Friday. Guggenheim initiated coverage on Humana in a research report on Wednesday. They set a "buy" rating and a $326.00 target price on the stock. Finally, Piper Sandler lifted their price target on Humana from $270.00 to $288.00 and gave the stock a "neutral" rating in a research note on Wednesday, January 15th. Seventeen investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat, Humana currently has a consensus rating of "Hold" and an average target price of $286.00.

Remove Ads

Humana Trading Up 0.9 %

Shares of HUM traded up $2.60 during mid-day trading on Friday, hitting $292.85. The company had a trading volume of 622,751 shares, compared to its average volume of 1,744,128. Humana Inc. has a 1-year low of $213.31 and a 1-year high of $406.46. The business's 50-day simple moving average is $265.56 and its 200-day simple moving average is $270.77. The stock has a market cap of $35.35 billion, a PE ratio of 29.46, a P/E/G ratio of 2.05 and a beta of 0.62. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) earnings per share for the quarter, beating analysts' consensus estimates of ($2.26) by $0.10. Humana had a net margin of 1.02% and a return on equity of 11.70%. Sell-side analysts forecast that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $3.54 annualized dividend and a yield of 1.21%. Humana's dividend payout ratio is presently 35.58%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.